News About: Pharm. Industry
Pfizer promptly launching Nicolet 4mg gum
Pfizer Korea launched Nicolet 4mg gum, an anti-smoking remedy on May 4 by means of importing via air shipment from the overseas because the existing 2mg product could not meet its ever increasing market demands.
D...
Novartis; local clinical study for combined anti-hypertension drugs.
Novartis Korea announced on May 4 to conduct a local clinical study for a combined anti-hypertension drug with Diovan (valsartan), an angiotensin receptor blocker, and Amodipin (amlodipin camsylate), a calcium channel...
Seminar on market analysis of original and generic drugs.
CAMM Pacific Korea (Representative: Lee Young-taek) plans a pharmaceutical management seminar titled "The market analysis of the original and generic drug sales" at the first floor auditorium of the Korea Federation o...
Dong-wha licensing in a new technology for anti-viral drugs
Dong-wha announced to license in a new technology development for an anti-viral drug using natural plants from Korea Bio Engineering Research Institute, which was accomplished by the chief researcher Kwon Doo-han of t...
Mr. Manuel Flores assigned to CEO of Bayer Korea.The top position of Bayer Healthcare in vacant so far has been occupied by Mr. Manuel Flores who comes from Venezuela as of May 1, 2005.
He served in Thailand and the Philipp...
|
New Drug R&D targeting more to commercialize
The Korea Society of Pharmaceutics (chairman: Shin Sang-cheol) took a symposium in a celebrating event of "A month of science" at Samsung Convention Center of SNU on April 29. In the conference, Dr. Shim Chang-goo, t...
Domestic industry capable to adopt global business strategies.
Many domestic drug companies are driving their diverse strategies for the global business in order to leap up as a global healthcare enterprise after realizing the limit of its growth in the domestic markets.
Most ...
Novartis to launch Stalevo, anti-parkinson drug.
Novartis Korea launched Stalevo a combined anti-parkinson drug with levo-dopa/carbidopa/entacapone,, on May 2.
The company said that 50% of the patients who treated with Levo-dopa, which was developed in 1960s for ...
Il Dong achieved 197.3 BW sales and 7.3% operating income.
Il Dong reported on April 29 for the FY2004 business performance (April 1, 2004 to Mar. 31, 2005) at 197.3 billion won of sales, about 15% up from the previous year of 210 billion won and 31,417 million of the operati...
Pfizer and Jeil to extend distribution agreement with Lyrica
The distribution agreement made between Pfizer Korea and Jeil Pharm. Co. will expire on May 31, 2005 and therefore mutually agreed to extend it on April 28 for an ongoing distribution of Lipitor and Neurontin in addit...
